BRIEF published on 08/09/2024 at 17:09, 2 years 2 months ago Subsidiaries of Vita 34 Reach Agreement with US Licensor Vita 34 FamiCordTx PBKM CAR-T Technology Biotechnology Agreement
PRESS RELEASE published on 08/09/2024 at 17:04, 2 years 2 months ago EQS-Adhoc: Subsidiaries of Vita 34 reach agreement with US licensor Vita 34 AG subsidiaries reach agreement with US licensor on CAR-T technology, settling previous lawsuit and securing new know-how licensing agreement Vita 34 AG Agreement Subsidiaries CAR-T Technology US Licensor
BRIEF published on 08/01/2024 at 12:44, 2 years 3 months ago Thomas Pfaadt Appointed as New Chief Financial Officer of Vita 34 AG Chief Financial Officer Finance Management Board Vita 34 AG Thomas Pfaadt
PRESS RELEASE published on 08/01/2024 at 12:39, 2 years 3 months ago Thomas Pfaadt appointed as new Chief Financial Officer of Vita 34 AG Thomas Pfaadt appointed as new CFO of Vita 34 AG, bringing 20+ years of experience. Management Board complete. Vita 34, leading cell bank in Europe, focusing on cell banking and investments in therapies CFO Vita 34 AG Investments Thomas Pfaadt Cell Banking
BRIEF published on 05/31/2024 at 08:38, 2 years 5 months ago Vita 34 Reports Significant Increases in Earnings and Cash Flow EBITDA Revenue Growth Operating Cash Flow Q1 2024 Earnings Vita 34
PRESS RELEASE published on 05/31/2024 at 08:33, 2 years 5 months ago Vita 34 significantly increases earnings and operating cash flow in the first quarter Vita 34 AG reports a significant increase in earnings and operating cash flow in the first quarter of 2024, with revenues up by 3.6% to EUR 18.6 million. EBITDA exceeds EUR 1.5 million Revenues Business Development Earnings Operating Cash Flow Vita 34 AG
BRIEF published on 04/30/2024 at 22:56, 2 years 6 months ago Vita 34 Sees Financial Growth and Improvement in 2023 Investment Strategies 2024 Outlook Vita 34 AG Financial Growth Increase In EBITDA
PRESS RELEASE published on 04/30/2024 at 22:51, 2 years 6 months ago Vita 34 returns to growth path in 2023 Vita 34 AG reports 11.8% revenue growth to EUR 77.1 million in 2023 despite challenging environment. EBITDA significantly improved to EUR 5.6 million EBITDA Revenue Growth Business Development Vita 34 AG Cell Bank
BRIEF published on 04/19/2024 at 12:33, 2 years 6 months ago Vita 34 Achieves Better Than Expected Financial Results for 2023 EBITDA Revenue Growth Financial Performance Earnings Report Vita 34 AG
PRESS RELEASE published on 04/19/2024 at 12:28, 2 years 6 months ago EQS-Adhoc: Vita 34 closes 2023 with significantly better results than expected based on preliminary figures Vita 34 AG exceeds 2023 earnings expectations with EUR 5.6 million EBITDA, forecasts revenues of EUR 81-88 million and EBITDA of EUR 6.5-8.0 million for 2024 Revenues EBITDA Forecast Earnings Vita 34 AG
Published on 11/06/2026 at 00:53, 1 hour 30 minutes ago Sekur Private Data Engages Darkstar Capital for Investor Awareness and Sekur Product Distribution
Published on 11/06/2026 at 00:45, 1 hour 38 minutes ago Gabriel Announces Closure of ICSID Annulment Proceedings
Published on 11/05/2026 at 23:20, 3 hours 3 minutes ago Health Canada Authorizes Moderna's mRNA Influenza and Combination Influenza and COVID-19 Vaccines
Published on 11/05/2026 at 22:05, 4 hours 18 minutes ago Innodata Reports Record Third Quarter 2026 Results
Published on 11/06/2026 at 00:05, 2 hours 18 minutes ago RBI: Announcement of the result of the voluntary public tender offer for all Addiko shares following expiration of the grace period
Published on 11/05/2026 at 22:05, 4 hours 18 minutes ago Quantinuum Reports Third Quarter 2026 Results and Raises Full-Year Revenue Outlook
Published on 11/05/2026 at 20:38, 5 hours 44 minutes ago freenet uses funds from Ceconomy sale for waipu.tv acquisition and share buyback
Published on 11/05/2026 at 20:37, 5 hours 46 minutes ago EQS-Adhoc: freenet AG decides on share buyback programme for up to EUR 75 million
Published on 11/05/2026 at 19:45, 6 hours 37 minutes ago Stabilus SE fulfills forecast for fiscal 2026 and adjusts 2030 medium-term targets
Published on 11/05/2026 at 18:21, 8 hours 1 minute ago Total number of voting rights and shares making up the share capital at October 31, 2026
Published on 11/05/2026 at 17:45, 8 hours 38 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 11/05/2026 at 17:29, 8 hours 53 minutes ago Notice of exercise of early redemption option of the subordinated note ISIN FR0010406082
Published on 11/05/2026 at 10:16, 16 hours 6 minutes ago Growth acceleration confirmed in the third quarter of 2026 All businesses growing, revenue up +6,5%
